These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 8187442

  • 1. Paget's disease of bone: five regimens of pamidronate treatment.
    Pepersack T, Karmali R, Gillet C, François D, Fuss M.
    Clin Rheumatol; 1994 Mar; 13(1):39-44. PubMed ID: 8187442
    [Abstract] [Full Text] [Related]

  • 2. Paget's disease of bone: early and late responses to three different modes of treatment with aminohydroxypropylidene bisphosphonate (APD).
    Harinck HI, Papapoulos SE, Blanksma HJ, Moolenaar AJ, Vermeij P, Bijvoet OL.
    Br Med J (Clin Res Ed); 1987 Nov 21; 295(6609):1301-5. PubMed ID: 3120987
    [Abstract] [Full Text] [Related]

  • 3. A single infusion of the bisphosphonate AHPrBP (APD) as treatment of Paget's disease of bone.
    Thiébaud D, Jaeger P, Gobelet C, Jacquet AF, Burckhardt P.
    Am J Med; 1988 Aug 21; 85(2):207-12. PubMed ID: 3261129
    [Abstract] [Full Text] [Related]

  • 4. Low dose intravenous 3-amino-1-hydroxypropylidene-1,1-bisphosphonate (APD) for the treatment of Paget's disease of bone.
    Cantrill JA, Buckler HM, Anderson DC.
    Ann Rheum Dis; 1986 Dec 21; 45(12):1012-8. PubMed ID: 3813665
    [Abstract] [Full Text] [Related]

  • 5. Pamidronate is effective for Paget's disease of bone refractory to conventional therapy.
    Wimalawansa SJ, Gunasekera RD.
    Calcif Tissue Int; 1993 Oct 21; 53(4):237-41. PubMed ID: 8275351
    [Abstract] [Full Text] [Related]

  • 6. Effects of intravenous pamidronate therapy on Paget's disease of bone.
    Bombassei GJ, Yocono M, Raisz LG.
    Am J Med Sci; 1994 Oct 21; 308(4):226-33. PubMed ID: 7942981
    [Abstract] [Full Text] [Related]

  • 7. Treatment of Paget's disease of bone with single dose intravenous pamidronate.
    Watts RA, Skingle SJ, Bhambhani MM, Pountain G, Crisp AJ.
    Ann Rheum Dis; 1993 Aug 21; 52(8):616-8. PubMed ID: 8215628
    [Abstract] [Full Text] [Related]

  • 8. Clinical experience with pamidronate in the treatment of Paget's disease of bone.
    Gallacher SJ, Boyce BF, Patel U, Jenkins A, Ralston SH, Boyle IT.
    Ann Rheum Dis; 1991 Dec 21; 50(12):930-3. PubMed ID: 1768163
    [Abstract] [Full Text] [Related]

  • 9. [Therapy of Paget's disease with bisphosphonate pamidronate (AHPrBP, formerly APD)].
    Scharla SH, Grauer A, Ziegler R.
    Klin Wochenschr; 1991 Jan 04; 69(1):25-30. PubMed ID: 2016845
    [Abstract] [Full Text] [Related]

  • 10. Clinical and biological effects of low doses of (3 amino-1 hydroxypropylidene)-1,1-bisphosphonate (APD) in Paget's disease of bone.
    Heynen G, Delwaide P, Bijvoet OL, Franchimont P.
    Eur J Clin Invest; 1982 Feb 04; 12(1):29-35. PubMed ID: 6802650
    [No Abstract] [Full Text] [Related]

  • 11. Clinical, biochemical, hematologic, and radiographic responses in Paget's disease following intravenous pamidronate disodium: a 2-year study.
    Gutteridge DH, Retallack RW, Ward LC, Stuckey BG, Stewart GO, Prince RL, Kent GN, Bhagat CI, Price RI, Thompson RI, Nicholson GC.
    Bone; 1996 Oct 04; 19(4):387-94. PubMed ID: 8894145
    [Abstract] [Full Text] [Related]

  • 12. Effective oral treatment of severe Paget's disease of bone with APD (3-amino-1-hydroxypropylidene-1,1-bisphosphonate); a comparison with combined calcitonin + EHDP (1-hydroxyethylidene-1,1-bisphosphonate).
    Fraser TR, Ibbertson HK, Holdaway IM, Rutland M, King A, Dodd G, Wattie DJ.
    Aust N Z J Med; 1984 Dec 04; 14(6):811-8. PubMed ID: 6442563
    [Abstract] [Full Text] [Related]

  • 13. Long-term efficacy of intravenous pamidronate in Paget's disease of bone.
    Grauer A, Klar B, Scharla SH, Zieglar R.
    Semin Arthritis Rheum; 1994 Feb 04; 23(4):283-4. PubMed ID: 8009261
    [No Abstract] [Full Text] [Related]

  • 14. Pamidronate sodium and calcitonin-resistant Paget's disease. Immediate response in a patient.
    Drake S, Massie JD, Postlethwaite AE, Palmieri GM.
    Arch Intern Med; 1989 Feb 04; 149(2):401-3. PubMed ID: 2783843
    [Abstract] [Full Text] [Related]

  • 15. A randomized clinical trial comparing oral alendronate and intravenous pamidronate for the treatment of Paget's disease of bone.
    Walsh JP, Ward LC, Stewart GO, Will RK, Criddle RA, Prince RL, Stuckey BG, Dhaliwal SS, Bhagat CI, Retallack RW, Kent GN, Drury PJ, Vasikaran S, Gutteridge DH.
    Bone; 2004 Apr 04; 34(4):747-54. PubMed ID: 15050907
    [Abstract] [Full Text] [Related]

  • 16. [A single infusion of Pamidronate (APD) in Paget's disease of bone].
    Thiébaud D, Jaeger P, Jacquet AF, Burckhardt P.
    Schweiz Med Wochenschr; 1989 Jan 21; 119(3):71-4. PubMed ID: 2711157
    [Abstract] [Full Text] [Related]

  • 17. Changes in serum HDL and LDL cholesterol in patients with Paget's bone disease treated with pamidronate.
    Montagnani A, Gonnelli S, Cepollaro C, Campagna MS, Franci MB, Pacini S, Gennari C.
    Bone; 2003 Jan 21; 32(1):15-9. PubMed ID: 12584031
    [Abstract] [Full Text] [Related]

  • 18. Intravenously administered pamidronate in the treatment of Paget's disease of bone.
    Tucci JR, Bontha S.
    Endocr Pract; 2001 Jan 21; 7(6):423-9. PubMed ID: 11747277
    [Abstract] [Full Text] [Related]

  • 19. Single-day intravenous pamidronate in Paget's disease.
    Hooper MJ, Clifton-Bligh P, Marel GM, Lang FV, Tancred J, McDowall D, Forman L.
    Semin Arthritis Rheum; 1994 Feb 21; 23(4):276-7. PubMed ID: 8009255
    [Abstract] [Full Text] [Related]

  • 20. Risedronate and pamidronate treatment in the clinical management of patients with severe Paget's disease of bone and acquired resistance to bisphosphonates.
    Rendina D, Mossetti G, Viceconti R, Sorrentino M, Nunziata V.
    Calcif Tissue Int; 2004 Sep 21; 75(3):189-96. PubMed ID: 15148558
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.